NCT06188819

Brief Summary

While surgery with anatomic reconstruction of prosthetic aortic infections and native infectious aortitis has become established over time, the ideal substitute is not clearly defined. The cryopreserved arterial allograft (AAC) recognized as resistant to infections not only presents availability problems making its use complicated, particularly in emergencies, with a certain number of long-term aneurysmal developments. The tubulized pericardium patch (PP), available in all cases, seems to give promising results in recent literature. The investigators propose a comparative study of these two substitutes in this indication. We carried out a two-center observational study including retrospectively from January 2010 to July 2023 all patients operated on for aortic prosthesis infection and native infectious aortitis with AAC reconstruction and prospectively PP patch reconstructions from July 2018 to July 2023. The diagnosis of infection was established according to the MAGIC criteria. The patients' preoperative comorbidities were collected to compare the groups. Postoperative morbidity and mortality was then compared. The medium-term evaluation consisted of comparing according to the Kaplan Meier method: postoperative mortality, permeability, reinfection rate, reoperation rate.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2010

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2010

Completed
14 years until next milestone

First Submitted

Initial submission to the registry

December 18, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 3, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2024

Completed
Last Updated

January 10, 2024

Status Verified

January 1, 2024

Enrollment Period

1 day

First QC Date

December 18, 2023

Last Update Submit

January 8, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Mortality

    Number of patients death during post operative stay

    day 30 post operative

  • Reintervention

    Rate of reintervention during post operative stay

    30 days, 6 months, 12 months, 24 months

  • Post operative Major cardiovascular adverse events (MACE)

    Rate of nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death

    day 30 post operative

Secondary Outcomes (2)

  • Permeability

    30 days, 6 months, 12 months, 24 months

  • Reinfection

    30 days, 6 months, 12 months, 24 months

Study Arms (2)

Cryopreserved arterial allograft

Aortic infection treated by cryopreserved arterial allograft

Procedure: Explantation of a previous aortic graft or endograft and reconstruction by arterial allograft or rolled pericardium

Rolled pericardium patch

Aortic infection treated by Pericardium patch rolled

Procedure: Explantation of a previous aortic graft or endograft and reconstruction by arterial allograft or rolled pericardium

Interventions

In situ reconstruction with explantation of the infected graft or endograft and reconstruction by allograft or pericardium

Cryopreserved arterial allograftRolled pericardium patch

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients operated on for a native infection or an aortic prosthesis who had pericardium or allograft reconstruction

You may qualify if:

  • All aortic intervention performed for native aortic infection reconstruction with patch or allograft
  • All aortic intervention performed for infected graft reconstruction with patch or allograft

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 18, 2023

First Posted

January 3, 2024

Study Start

January 1, 2010

Primary Completion

January 2, 2010

Study Completion

June 15, 2024

Last Updated

January 10, 2024

Record last verified: 2024-01